These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 15890894)

  • 21. Influence of LDL receptor gene mutations and the R3500Q mutation of the apoB gene on lipoprotein phenotype of familial hypercholesterolemic patients from a South European population.
    Real JT; Chaves FJ; Ejarque I; García-García AB; Valldecabres C; Ascaso JF; Armengod ME; Carmena R
    Eur J Hum Genet; 2003 Dec; 11(12):959-65. PubMed ID: 14508510
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of low-density lipoprotein receptor mutational class on carotid atherosclerosis in patients with familial hypercholesterolemia.
    Junyent M; Gilabert R; Jarauta E; Núñez I; Cofán M; Civeira F; Pocoví M; Mallén M; Zambón D; Almagro F; Vega J; Tejedor D; Ros E
    Atherosclerosis; 2010 Feb; 208(2):437-41. PubMed ID: 19717150
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiplex ligation-dependent probe amplification of LDLR enhances molecular diagnosis of familial hypercholesterolemia.
    Wang J; Ban MR; Hegele RA
    J Lipid Res; 2005 Feb; 46(2):366-72. PubMed ID: 15576851
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of common sequence variations of familial hypercholesterolemia in Taiwan using DNA mass spectrometry.
    Chiou KR; Charng MJ
    J Clin Lipidol; 2017; 11(2):386-393.e6. PubMed ID: 28502495
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A DNA microarray for the detection of point mutations and copy number variation causing familial hypercholesterolemia in Europe.
    Stef MA; Palacios L; Olano-Martín E; Foe-A-Man C; van de Kerkhof L; Klaaijsen LN; Molano A; Schuurman EJ; Tejedor D; Defesche JC
    J Mol Diagn; 2013 May; 15(3):362-72. PubMed ID: 23537714
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of a recurrent insertion mutation in the LDLR gene in a Pakistani family with autosomal dominant hypercholesterolemia.
    Ajmal M; Ahmed W; Sadeque A; Ali SH; Bokhari SH; Ahmed N; Qamar R
    Mol Biol Rep; 2010 Dec; 37(8):3869-75. PubMed ID: 20217239
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Update of the molecular basis of familial hypercholesterolemia in The Netherlands.
    Fouchier SW; Kastelein JJ; Defesche JC
    Hum Mutat; 2005 Dec; 26(6):550-6. PubMed ID: 16250003
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of the denaturing gradient gel electrophoresis (DGGE) method for mutational screening of patients with familial hypercholesterolaemia (FH) and Familial defective apolipoprotein B100 (FDB).
    Azian M; Hapizah MN; Khalid BA; Khalid Y; Rosli A; Jamal R
    Malays J Pathol; 2006 Jun; 28(1):7-15. PubMed ID: 17694954
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Identification of a novel splice mutation of low density lipoprotein receptor gene in a Chinese family with familial hypercholesterolemia].
    Lin J; Wang LY; Liu S; Pan XD; Du LP; Shi FR; Qin YW; Zhao Q; Guo HY
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Feb; 21(1):14-8. PubMed ID: 14767901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study.
    Pirillo A; Garlaschelli K; Arca M; Averna M; Bertolini S; Calandra S; Tarugi P; Catapano AL;
    Atheroscler Suppl; 2017 Oct; 29():17-24. PubMed ID: 28965616
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Seven DNA polymorphisms in the LDL receptor gene: application to the study of familial hypercholesterolemia in Spain.
    Chaves FJ; Puig O; García-Sogo M; Real J; Gil JV; Ascaso J; Carmena R; Armengod ME
    Clin Genet; 1996 Jul; 50(1):28-35. PubMed ID: 8891383
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Chinese homozygote of familial hypercholesterolemia: identification of a novel C263R mutation in the LDL receptor gene.
    Wang D; Wu B; Li Y; Heng W; Zhong H; Mu Y; Wang J
    J Hum Genet; 2001; 46(3):152-4. PubMed ID: 11310584
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic analysis of familial hypercholesterolaemia in Western Australia.
    Hooper AJ; Nguyen LT; Burnett JR; Bates TR; Bell DA; Redgrave TG; Watts GF; van Bockxmeer FM
    Atherosclerosis; 2012 Oct; 224(2):430-4. PubMed ID: 22883975
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular characterization of familial hypercholesterolemia in Spain: identification of 39 novel and 77 recurrent mutations in LDLR.
    Mozas P; Castillo S; Tejedor D; Reyes G; Alonso R; Franco M; Saenz P; Fuentes F; Almagro F; Mata P; Pocoví M
    Hum Mutat; 2004 Aug; 24(2):187. PubMed ID: 15241806
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Next-generation-sequencing-based identification of familial hypercholesterolemia-related mutations in subjects with increased LDL-C levels in a latvian population.
    Radovica-Spalvina I; Latkovskis G; Silamikelis I; Fridmanis D; Elbere I; Ventins K; Ozola G; Erglis A; Klovins J
    BMC Med Genet; 2015 Sep; 16():86. PubMed ID: 26415676
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of a common low density lipoprotein receptor mutation (C163Y) in the west of Scotland.
    Lee WK; Haddad L; Macleod MJ; Dorrance AM; Wilson DJ; Gaffney D; Dominiczak MH; Packard CJ; Day IN; Humphries SE; Dominiczak AF
    J Med Genet; 1998 Jul; 35(7):573-8. PubMed ID: 9678702
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of genetic versus clinical diagnosis in familial hypercholesterolemia.
    Civeira F; Ros E; Jarauta E; Plana N; Zambon D; Puzo J; Martinez de Esteban JP; Ferrando J; Zabala S; Almagro F; Gimeno JA; Masana L; Pocovi M
    Am J Cardiol; 2008 Nov; 102(9):1187-93, 1193.e1. PubMed ID: 18940289
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expanding the genetic spectrum for Chinese familial hypercholesterolemia population with six genetic mutations identified using a next-generation sequencing-based laboratory-developed screening test.
    Jingxin S; Shitong C
    Mol Genet Genomic Med; 2022 Dec; 10(12):e2070. PubMed ID: 36226792
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low-Cost High-Throughput Genotyping for Diagnosing Familial Hypercholesterolemia.
    Ibrahim S; van Rooij J; Verkerk AJMH; de Vries J; Zuurbier L; Defesche J; Peter J; Schonck WAM; Sedaghati-Khayat B; Kees Hovingh G; Uitterlinden AG; Stroes ESG; Reeskamp LF
    Circ Genom Precis Med; 2023 Oct; 16(5):462-469. PubMed ID: 37675602
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The apolipoprotein B R3500Q gene mutation in Spanish subjects with a clinical diagnosis of familial hypercholesterolemia.
    Castillo S; Tejedor D; Mozas P; Reyes G; Civeira F; Alonso R; Ros E; Pocoví M; Mata P
    Atherosclerosis; 2002 Nov; 165(1):127-35. PubMed ID: 12208478
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.